Loading clinical trials...

SI-6603 Versus Placebo in Patients With Lumbar Disc Herniation | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2/3NCT00634946

SI-6603 Versus Placebo in Patients With Lumbar Disc Herniation

The purpose of this study is to determine whether SI-6603 is effective in the treatment of lumbar disc herniation.

Lead sponsor: Seikagaku Corporation•8 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusCOMPLETED

PhasePHASE2/PHASE3

Enrollment195

Start dateJan 2008

Last updatedMar 23, 2023

Condition

Lumbar Vertebra Hernia

Locations shown

Chugoku Area

Chugoku

Chubu Area

Chūbu

Hokkaido Area

Hokkaido

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 23, 2023Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions